ABILIFY- aripiprazole tablet ABILIFY- aripiprazole solution ABILIFY- aripiprazole tablet, orally disintegrating ABILIFY- arip United States - English - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

OTSUKA SODIUM CHLORIDE INJECTION 10% (大塚食塩注10%) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka sodium chloride injection 10% (大塚食塩注10%)

otsuka pharmaceutical factory, inc. - sodium chloride - injection

OTSUKA Sodium Chloride Injection BP N-S-S (0.9% Sodium Chloride Intravenous Infusion B.P.) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

otsuka sodium chloride injection bp n-s-s (0.9% sodium chloride intravenous infusion b.p.)

luen wah medical co. sdn. bhd. - sodium chloride (salt) -

SODIUM CHLORIDE INJECTION BP 0.9% Singapore - English - HSA (Health Sciences Authority)

sodium chloride injection bp 0.9%

luen wah medical company (singapore) private limited - sodium chloride - injection - sodium chloride 0.9%

OTSUKA NORMAL SALINE Injection (20mL) (大塚生食注（20mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka normal saline injection (20ml) (大塚生食注（20ml）)

otsuka pharmaceutical factory, inc. - sodium chloride - injection

OTSUKA NORMAL SALINE Injection (500mL Soft Bag) (大塚生食注（500mLソフトバッグ）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka normal saline injection (500ml soft bag) (大塚生食注（500mlソフトバッグ）)

otsuka pharmaceutical factory, inc. - sodium chloride - injection

OTSUKA NORMAL SALINE Injection (50mL) (大塚生食注（50mL）) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

otsuka normal saline injection (50ml) (大塚生食注（50ml）)

otsuka pharmaceutical factory, inc. - sodium chloride - injection

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9% Singapore - English - HSA (Health Sciences Authority)

sodium chloride intravenous infusion bp 0.9%

luen wah medical company (singapore) private limited - sodium chloride - injection - 0.9 g/100 ml - sodium chloride 0.9 g/100 ml

OTSU-D5NS 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

otsu-d5ns 5% dextrose and 0.9% sodium chloride injection usp

luen wah medical co. sdn. bhd. - dextrose monohydrate/dextrose/glucose; sodium chloride (salt) -

OTSU-D1015NS 0.18% SODIUM CHLORIDE AND 10% DEXTROSE INTRAVENOUS INFUSION B.P Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

otsu-d1015ns 0.18% sodium chloride and 10% dextrose intravenous infusion b.p

luen wah medical co. sdn. bhd. - glucose anhydrous; sodium chloride (salt) -